AFT Pharmaceuticals CEO Dr Hartley Atkinson 22.5.22 (9.12am) Along with a FY22 operating profit in line with guidance, AFT Pharmaceuticals has struck its dividend policy and guides to a maiden payment in FY23. The company’s 31 March 2022 results show strong growth across all regions, new products and growth in product royalties and licensing income. […]